Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma

Patients with multiple myeloma are at elevated risk of venous thromboembolism (VTE), the second leading cause of death in patients with cancer, but physician adherence to VTE prevention guidelines is low. Several organizations partnered in designing and implementing a 2-year quality improvement (QI)...

Full description

Bibliographic Details
Main Authors: Rachid Baz MD, Roy Furman MD, PhD, Katherine Simondsen PharmD, BCOP, Christine Stone PhD, MBA
Format: Article
Language:English
Published: SAGE Publishing 2020-06-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820930204